VKTX logo

Viking Therapeutics (VKTX) Current Assets

Annual Current Assets

$367.23 M
+$200.19 M+119.84%

31 December 2023

VKTX Current Assets Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Quarterly Current Assets

$936.65 M
-$9.07 M-0.96%

30 September 2024

VKTX Quarterly Current Assets Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

VKTX Current Assets Performance

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year+119.8%+145.7%
3 y3 years+43.4%+317.6%
5 y5 years+21.5%+223.8%

VKTX Current Assets High & Low

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3 yearsat high+119.8%-3.1%+526.7%
5 y5 yearsat high+119.8%-3.1%+526.7%
alltimeall timeat high-3.1%>+9999.0%

Viking Therapeutics Current Assets History

DateAnnualQuarterly
Sept 2024
-
$936.65 M(-1.0%)
June 2024
-
$945.72 M(-2.1%)
Mar 2024
-
$966.34 M(+163.1%)
Dec 2023
$1.26 M(-15.0%)
$367.23 M(-3.7%)
Sept 2023
-
$381.30 M(-4.5%)
June 2023
-
$399.37 M(+167.2%)
Mar 2023
-
$149.47 M(-10.5%)
Dec 2022
$1.49 M(+1011.2%)
$167.04 M(+1.1%)
Sept 2022
-
$165.15 M(-8.2%)
June 2022
-
$179.86 M(-7.0%)
Mar 2022
-
$193.30 M(-8.2%)
Dec 2021
$134.00 K(-66.3%)
$210.53 M(-6.1%)
Sept 2021
-
$224.28 M(-5.6%)
June 2021
-
$237.66 M(-4.9%)
Mar 2021
-
$249.86 M(-2.4%)
Dec 2020
$398.00 K(-47.3%)
$256.10 M(-2.7%)
Sept 2020
-
$263.13 M(-2.8%)
June 2020
-
$270.62 M(-2.1%)
Mar 2020
-
$276.45 M(-2.5%)
Dec 2019
$755.00 K
$283.50 M(-2.0%)
Sept 2019
-
$289.26 M(-1.5%)
June 2019
-
$293.64 M(-1.8%)
DateAnnualQuarterly
Mar 2019
-
$299.14 M(-1.0%)
Dec 2018
$179.00 K(-33.7%)
$302.13 M(-1.5%)
Sept 2018
-
$306.62 M(+112.5%)
June 2018
-
$144.26 M(+83.2%)
Mar 2018
-
$78.73 M(+260.3%)
Dec 2017
$270.00 K(-51.9%)
$21.85 M(+89.6%)
Sept 2017
-
$11.53 M(-19.2%)
June 2017
-
$14.26 M(-2.8%)
Mar 2017
-
$14.67 M(+5.0%)
Dec 2016
$560.90 K(+136.2%)
$13.97 M(-10.6%)
Sept 2016
-
$15.62 M(-14.7%)
June 2016
-
$18.31 M(+50.6%)
Mar 2016
-
$12.16 M(-20.0%)
Dec 2015
$237.50 K(-89.5%)
$15.20 M(-19.7%)
Sept 2015
-
$18.93 M(-15.0%)
June 2015
-
$22.27 M(+6079.1%)
Mar 2015
-
$360.40 K(-53.4%)
Dec 2014
$2.27 M(>+9900.0%)
$773.70 K(-15.8%)
June 2014
-
$919.40 K(+965.4%)
Mar 2014
-
$86.30 K
Dec 2013
$800.00(>+9900.0%)
-
Dec 2012
$0.00
-

FAQ

  • What is Viking Therapeutics annual total current assets?
  • What is the all time high annual current assets for Viking Therapeutics?
  • What is Viking Therapeutics annual current assets year-on-year change?
  • What is Viking Therapeutics quarterly total current assets?
  • What is the all time high quarterly current assets for Viking Therapeutics?
  • What is Viking Therapeutics quarterly current assets year-on-year change?

What is Viking Therapeutics annual total current assets?

The current annual current assets of VKTX is $367.23 M

What is the all time high annual current assets for Viking Therapeutics?

Viking Therapeutics all-time high annual total current assets is $367.23 M

What is Viking Therapeutics annual current assets year-on-year change?

Over the past year, VKTX annual total current assets has changed by +$200.19 M (+119.84%)

What is Viking Therapeutics quarterly total current assets?

The current quarterly current assets of VKTX is $936.65 M

What is the all time high quarterly current assets for Viking Therapeutics?

Viking Therapeutics all-time high quarterly total current assets is $966.34 M

What is Viking Therapeutics quarterly current assets year-on-year change?

Over the past year, VKTX quarterly total current assets has changed by +$555.35 M (+145.65%)